Opening of Bids - Liberty Tower TIF Project – Parking Garage Proj No. 123-054R - Browning Chapman

Home Browse Search

Browning Chapman, LLC DRUG FREE WORKPLACE POLICY Chapter 5 Page 15 of 477 © Safety Resources, Inc. 2016 d. A donor will have up to two hours to provide a specimen. If he leaves before two hours and does not give a sample, he will be considered having refused to test. The donor will be afforded privacy for the urine collection unless the collector observes evidence of an employee’s attempt to tamper with a specimen, or the temperature range of the original specimen was out of normal range, or the specimen appeared to have been tampered with, or the specimen was determined invalid by the laboratory. e. Upon completion of testing the donor will be given a copy of form CCF (Custody and Control Form) 2. Laboratory Testing Procedures: All substance analysis will be done in SAMHSA laboratories certified by DHHS (Department of Health and Human Services). Laboratory procedures will include: a. Initial screen on each specimen. In the event that the initial test is positive a confirmation test will automatically be performed using the GCMS method. A test is considered positive if the detected level of the drug is at or above the cutoff level listed herein. CCS recommends that no adverse action or discipline be taken against any worker or applicant for employment on the basis of any positive test that has not been “confirmed”. b. Validity testing on each specimen will automatically be performed. Each specimen is measured for creatinine level, specific gravity, and pH to determine if any of the following occurred: Adulterants or foreign substance were added to the urine; The specimen was substituted; or, The urine was diluted. c. The laboratory will report all results to the MRO (Medical Review Officer). The MRO will make a final determination as to the verified result and the results will be reported to the designated contractor’s employee representative. 3. MRO Procedures: All drug testing shall come under the control and supervision of a physician with confidentiality protected in accordance with state law and the “American Medical Association’s Code of Ethical Conduct for Physicians Providing Occupational Medical Services” or the Medical Review Officer Manual, as developed by the National Institute on Drug Abuse (NIDA). All testing results shall be verified by a MRO. The MRO is a licensed physician responsible for receiving laboratory results generated by a substance abuse testing program, who has knowledge of substance abuse disorders, and who has received appropriate medical training to interpret and evaluate an individual’s medical history, and any other relevant biomedical information, as certified by either the American Medical Association (AMA) or the American College of Occupational and Environmental Medicine (ACOEM). He provides a medical review on all test results issued by the laboratory as follows: a. If the laboratory result is negative, the review is completed and a negative result is mailed. b. If the laboratory result is positive, adulterated, substituted, or invalid, the MRO will : Make one attempt to contact the donor by telephone to inform him of the results and complete an interview to determine whether a legitimate medical explanation exists for the result reported by the lab. If he was able to leave a message, but unable to talk to the employee by 10:00 AM of the following workday he will call the employer to report the results. In any case, the employee always has the opportunity to discuss the test results with the MRO. c. If the laboratory reports an invalid result to the MRO, the MRO will contact the employee and inquire as to medications the employee may have taken that may interfere with some immunoassay tests. If the employee provides an acceptable explanation, the test will be canceled and no further testing will be required unless a negative result is required to obtain a valid CCS card. If the employee is unable to provide an acceptable explanation and denies having adulterated the specimen, the test will be canceled, and a second collection must take place immediately under direct observation.